Severe acute toxoplasmosis infection following ustekinumab treatment in a patient with psoriasis vulgaris

A 26-year-old man undergoing therapy with 45 mg ustekinumab (Stelara) for chronic psoriasis vulgaris was referred by his general practitioner to an infectious diseases department for fatigue, fever, night sweating, generalised lymphadenomegaly and unexplained weight loss. Physical examination reveal...

Full description

Saved in:
Bibliographic Details
Published in:BMJ Case Rep
Main Authors: Muslimani, Muhammad A, Di Palma-Grisi, James
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2019
Subjects:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700578/
https://ncbi.nlm.nih.gov/pubmed/31420435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230415
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items